p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma

Oncogene

Volumn 17, Issue 7, 1998, Pages 819-824

  Holmgren, Lars ^a   Jackson, Geraldine ^b   Arbiser, Jack ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Dormancy; Neoplasia

Indexed keywords

ANGIOGENESIS INHIBITOR; PROTEIN P53;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; FIBROSARCOMA; GENE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALIA; MURINAE;

EID: 0032552020     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201993     Document Type: Article

References (28)

1. Bouck N, Stellmach V and Hsu S. (1996). Adv. Cancer Res., 69, 135-174.
2. Dameron KM, Volpert OV, Tainsky MA and Bouck N. (1994). Science, 265, 1582-1584.
3. Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B and Friend SH. (1990). Mol. Cell. Biol., 10, 5772-5781.
4. Folkman J. (1995). The Molecular Basis of Cancer. Mendelsohn J. Howley PM, Israel MA and Liotta LA (eds). WB Saunders: Philadelphia, pp. 206-232.
5. Gavrieli Y. Sherman Y and Ben-Sasson SA. (1992). J. Cell. Biol., 119, 493-501.
6. Grugel S, Finkenzeller G, Weindel K, Barleon B and Marmé D. (1995). J. Biol. Chem., 270, 25915-25919.
7. Hanahan D and Folkman J. (1996). Cell, 86, 353-364.
8. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
9. Holmgren L. (1996). Cancer and Met. Rev., 15, 241-245.
10. Holmgren L, O'Reilly MS and Folkman J. (1995). Nature Med., 1, 149-153.
11. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley E, Fisher DE, Housman DE and Jacks T. (1994). Science, 266, 807-810.
12. Martinez J, Georgoff I, Martinez I and Levine A. (1991). Genes Dev., 5, 151-159.
13. Meyer JL, Van Kersen I, Becker B and Hahn GM. (1985). Int. J. Rad. One. Biol. Phys., 11, 973-981.
14. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR and Folkman J. (1997). Cell, 88, 277-285.
15. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH and Folkman J. (1994). Cell, 79, 315-328.
16. Parangi S, O'Reilly MS, Christofori G, Holmgren L, Grosfeld J, Folkman J and Hanahan D. (1996). Proc. Natl. Acad. Sci. USA, 93, 2002-2007.
17. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Sasazuki T and Kerbel RS. (1995). Cancer Res., 55, 4575-4580.
18. Sambrook J, Fritsch EF and Maniatis T. (1989). Molecular cloning, a laboratory manual. Cold Spring Harbor Laboratory Press, New York.
19. Shweiki D, Itin A, Soffer D and Keshet E. (1992). Nature, 359, 843-845.
20. Symonds H, Krall L, Remington L, Aenz-Robles M, Lowe S, Jacks T and Van Dyke T. (1994). Cell, 78, 703-711.
21. Tanaka T, Manome Y, Wen PY, Kufe DW and Fine HA. (1996). Angiogenesis Antagonists. Cambridge Healthtech Institute: Boston.
22. Teicher BA, Dupuis N, Kusomoto T, Robinson MF, Liu F, Menon K and Coleman CN. (1995). Rad. Oncol. Invest., 2, 269-276.
23. Teicher BA, Sotomayor AA and Huang ZD. (1992). Cancer Res, 52, 6702-6704.
24. Van Meir EG, Polverini PJ and Chazin VR, Su Hang HJ, de Tribolet N and Cavenee WE. (1994). Nature Gen., 8, 171-176.
25. Vogelstein B and Kinzler KW. (1993). TIGS, 9, 138-141.
26. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT and Jacks T. (1994). Science, 7, 480-484.
27. Yonisch-Rouch E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M. (1991). Nature, 352, 345-347.
28. Zhang W-W, Fang X, Mazur W, French BA, Georges RN and Roth JA. (1994). Cancer Gene Ther., 1, 5-13.